200 Clinical-Grade Genomic Analyses.
One Intelligent Platform.
We're inviting 100 genetics researchers to pilot Genomic Sentinel before it's publicly available — and tell us how it changes your research.
Full platform access. No cost. Your feedback shapes the future.
Only 100 spots available. Application reviewed within 24 hours.
The Pilot Program
We Built This for Researchers Like You.
Genomic Sentinel transforms static genomic reports into living, continuously updated intelligence — covering 200 clinical-grade analyses across pharmacogenomics, oncology, rare variants, multi-omics, and more. Before we open to the public, we're inviting 100 researchers to pilot the platform and tell us what they find.
Full Platform Access
All 200 analyses across pharmacogenomics, oncology, rare variants, epigenetics, multi-omics, and more — nothing locked or restricted.
Exclusive Pilot Access
Be among the first 100 researchers to test Genomic Sentinel in your lab. Run real analyses on real data with full platform capabilities.
Your Feedback Shapes the Platform
We're not running a passive trial. We want to hear what works, what doesn't, and what would make Genomic Sentinel indispensable to your lab.
🔬Pilot program is limited to 100 researchers. 100 spots remaining.
Join the Pilot
Tell Us About Your Research
We'll review your application and send login credentials to your email within 24 hours.
The Platform
200 Analyses. Every Dimension of Genomic Intelligence.
Genomic Sentinel covers the full clinical and research spectrum — from core variant analysis to advanced multi-omics, pharmacogenomics, oncology, longevity, neuroscience, immunology, and beyond.
+ 183 more analyses across every major organ system and research domain.